Admin Control Panel

New Post | Settings | Change Layout | Edit HTML | Edit posts | Sign Out


March20 podcast Dr Hazen
anti-TMA pill in a year or 2 ? (scroll 12 mins)

Additional info:
MEBO Karen
at UK Findacure conf 2020

Scroll down and select country

MEBO Map Testing & Meetups

Full details :
want listed ? contact

MEBO - UBIOME study 2018



MEBO Gut Microbiome Study
"Microbial Basis of Systemic Malodor and PATM Conditions (PATM)"
Funded by uBiome Research Grant

"Microbial Basis of Systemic Malodor and PATM Conditions (PATM)"

Dynamics of the Gut Microbiota in
Idiopathic Malodor Production

Started May 2018 - Ongoing

Current people sent kits : 100/100
3 kits per person


Participation info : LINK English

MEBO Private Facebook Group
to join : go to
or contact
Join/Watch the weekly
BO Sufferers Podcasts



TMAU Petition world
TMAU UK end total:262
TMAU UK ends 23/01/20
TMAU Petition USA end total 204
USA : Moveon open
TMAU (Dominican)
Metabolomic Profiling Study

Start : Aug 2016
Stage 1 : 27 Canadian volunteers to test
Latest click here (26 oct) :
17 samples returned

Note : Stage 1 is Canada only.
Return cut-off date : passed
Analysis can take 6/8 weeks
Analysis start in/before Nov
MEBO Research is a
NORD Member Organization
See RareConnect TMAU

Popular Posts (last 30 days)

Upcoming get-togethers

Let us know if you want a meetup listed
Follow MeBOResearch on Twitter

Blog Archive

Denver TMAU Test Lab survey click here
click to Read more/less

USA survey for anyone who wants to improve Denver TMAU test

begun : Dec22
end : no ending for now

A trainee genetic counselor is working at the Denver TMAU test lab. Probably as part of her training. As a project she wishes feedback on any aspect of the Denver TMAU test and process. You can fill in the survey and/or email her (email address is in survey). It's meant for USA people, but perhaps others can give their view too (as we have so few opportunities).

quote from her rareconnect post

"Hello all! I wanted to make you aware of a research study being conducted to better understand the experience and needs of individuals with trimethylaminuria with a goal of being able to create improved patient and healthcare provider education materials. Any participation is completely voluntary and all responses remain confidential. Feel free to use the contact information within the link with any questions or share the survey with others with TMAU."

see this post for more details

Sunday, March 22, 2009

An Interpretation of the Nigel Manning interview : part 1

We are grateful to the recent interview Nigel Manning, the main tester of TMAU in the UK, gave to the blog recently. It greatly helps the sufferers in our understanding of the issue.

The interview can be read here

It is important that body odor sufferers are aware of the testers out there, as well as their testing procedures, influences, and thoughts on the subject. Since so few labs test for TMAU worldwide, it seems they may not have an internationally agreed test protocol. This is the first in a series of posts about the interview, in an attempt to make sense of what was said (to fully absorb the information)

These posts will be an attempt to analyze the interviews and try and fully absorb what was said. Clinical science in it's early stages can be very subjective, and you could say TMAU testing is at a very early stage of it's development (until governments realise how common it is and set standards). Anything that can be clarified later on will be corrected.

Trimethylaminuria Test Range
Nigel Mannings test range seems to be :
The ‘normal’ ranges were established early on by asking for volunteers (from the staff here at the hospital). TMA is regarded as normal if the concentration is below 11 micromoles per millimole of creatinine. TMA-oxide’s normal range is below 147 and the ratio of TMA to TMO is normal below 0.21.
TMA = trimethylamine
TMO = trimethylamine-n-oxide (the normal odorless metabolite)

Mr Manning seems to have defined the range levels himself (?), although it is clear he is well-read in TMAU medical papers. The normal concentration of TMA-creatinine is set at 11, whereas in 2 other TMAU papers the setting was around 18
Most individuals (with normal TMA N-oxidation capacity) excrete >95% of the combined TMA/TMANO load as TMANO or have a urinary TMA concentration of <18

Concentration of unmetabolized TMA in the urine. A urinary concentration of free TMA of 10µg/mL (18-20 µmol/mmol creatinine) or higher, correlating with a urinary output of TMA of about 15 to 20 mg/day, appears to represent a threshold for the presence of the fishy body odor associated with the disorder [Mitchell & Smith 2001].
Mr Manning also seems to include high TMA-n-oxide levels as indicative of TMAU, whereas it is unclear if others do this, since TMA-n-Oxide is the odorless final metabolite. Presumably such a condition (high TMA-n-o) would be part of his diagnosis of the 'secondary TMAU' spectrum, since it is clear TMA was metabolized at least.

The Sheffield lab is well-known as being possibly the only lab where forum posters on english-language body odor forums indicate they were positive for TMAU2. TMAU2 is generally accepted as existing, so the question is more a case of why no-one seems to be positive for this elsewhere ?
Substrate overload of FMO3 enzyme activity resulting from either an excess of dietary precursors of TMA or variations in gut fauna, causing increased release of TMA. This type of trimethylaminuria is characterized by a high concentration of TMA in the urine, but a normal urinary TMA/TMA N-oxide ratio.


Post a Comment